(Q58409727)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

author name string

B M Clary

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

E C Coveney

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

D G Blazer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

R Philip

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

language of work or name

1 reference

1 August 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

174-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

cites work

Cancer statistics, 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980285-6

7 January 2021

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980285-6

7 January 2021

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980285-6

7 January 2021

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980285-6

7 January 2021

Tumor-rejection antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980285-6

7 January 2021

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980285-6

7 January 2021

10.1016/S0039-6060(96)80285-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8751580%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference